
    
      35 patients and 10 controls were planned to be included in the study. Urine will be collected
      from patients before and after one month of medical treatment (alpha-blocker). After being
      centrifuged at 5000 g for 10 minutes, urine will be stored at -80 Â° C. At the end of the
      study, urinary glycosaminoglycan levels will be studied by spectrophotometric method. Urine
      GAG levels and pre and post treatment uroflowmetry, IPSS, overactive bladder symptom score,
      bladder frequency volume chart, post void residual urine volume will be compared.
    
  